<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Biogen Idec on its USD 32.5 milliontakeover of Panima Pharmaceuticals AG | Pestalozzi Attorneys at Law

Pestalozzi advised Biogen Idec on its USD 32.5 milliontakeover of Panima Pharmaceuticals AG

12.2010

Biogen, a Biotech company with the leading portfolio of medicines to treat multiple sclerosis (MS) aquired Swiss Biotech company Panima. Pestalozzi advised on all aspects of the transaction.

To the top